References
- Bivegete S, McNaughton AL, Trickey A, et al. Estimates of hepatitis B virus prevalence among general population and key risk groups in EU/EEA/UK countries: a systematic review. Eurosurveillance. 2023;28(30):2200738.
- Hepatitis B [Internet]; [cited 2025 June 30 ] Available from: https://www.who.int/news-room/fact-sheets/detail/hepatitis-b.
- Seto W-K, Lo Y-R, Pawlotsky J-M, Yuen M-F. Chronic hepatitis B virus infection. The Lancet. 2018;392(10161):2313–24.
- Lamontagne RJ, Bagga S, Bouchard MJ. Hepatitis B virus molecular biology and pathogenesis. Hepatoma Res. 2016;2:163–86.
- Iannacone M, Guidotti LG. Immunobiology and pathogenesis of hepatitis B virus infection. Nat Rev Immunol. 2022;22(1):19–32.
- Saitta C, Pollicino T, Raimondo G. Occult Hepatitis B Virus Infection: An Update. Viruses. 2022;14(7):1504.
- Koffas A, Kumar M, Gill US, Jindal A, Kennedy PTF, Sarin SK. Chronic hepatitis B: the demise of the ‘inactive carrier’ phase. Hepatol Int. 2021;15(2):290–300.
- Sharma SK, Saini N, Chwla Y. Hepatitis B Virus: Inactive carriers. Virol J. 2005;2(1):82.
- Guidelines for the prevention, diagnosis, care and treatment for people with chronic hepatitis B infection2024;
- Zhang Q, Cai D-C, Hu P, Ren H. Low-level viremia in nucleoside analog-treated chronic hepatitis B patients. Chin Med J (Engl). 2021;134(23):2810.
- Viral Hepatitis Surveillance and Case Management - Hepatitis B | CDC2025; [cited 2025 July 20 ] Available from: https://www.cdc.gov/hepatitis/statistics/surveillanceguidance/HepatitisB.htm.
- Coffin CS, Zhou K, Terrault NA. New and Old Biomarkers for Diagnosis and Management of Chronic Hepatitis B Virus Infection. Gastroenterology. 2019;156(2):355-368.e3.
- Molade JK, Onifade AA, Jimoh MA, et al. Estimation Of Immunological And Biochemical Parameters In Hepatitis B Positive Patients. Ann Ib Postgrad Med. 2020;18(1):31–6.
- Wang J, Pu Y, Gong Y, Li Z, Zhu X. A statistical analysis of the correlations among various types of clinical indexes for patients with chronic hepatitis B. Medicine (Baltimore). 2020;99(8):e19201.
- Sakugawa H. Correlation between serum transaminase activity and virus load among patients with chronic liver disease type B. Hepatol Res. 2001;21(2):159–68.
- Xiang Y, Yang Y, Chen P, et al. Analysis of serum hepatitis B virus RNA levels among HBsAg and HBsAb copositive patients and its correlation with HBV DNA. Medicine (Baltimore). 2021;100(40):e27433.
- Cai J, Wu W, Wu J, et al. Prevalence and clinical characteristics of hepatitis B surface antigen-negative/hepatitis B core antibody-positive patients with detectable serum hepatitis B virus DNA. Ann Transl Med. 2022;10(1):25–25.
- Eidi Nita M, Gaburo N, Cheinquer H, et al. Patterns of viral load in chronic hepatitis B patients in Brazil and their association with ALT levels and HBeAg status. Ann Hepatol. 2009;8(4):339–45.
- Li J, Zhang T-Y, Song L-W, et al. Role of quantitative hepatitis B core antibody levels in predicting significant liver inflammation in chronic hepatitis B patients with normal or near-normal alanine aminotransferase levels. Hepatol Res. 2018;48(3):E133–45.
- Yao K, Wang J, Wang L, et al. Association of anti-HBc and liver inflammation in HBeAg-negative chronic hepatitis B virus-infected patients with normal ALT and detectable HBV DNA. J Med Virol. 2022;94(2):659–66.
- Demir NA, Kolgelier S, Ozcimen S, et al. Evaluation of the Relation Between Hepatic Fibrosis and Basic Laboratory Parameters in Patients With Chronic Hepatitis B Fibrosis and Basic Laboratory Parameters. Hepat Mon. 2014 April; 14(4):e16975